A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
一项前瞻性多中心II期研究,旨在评估FOLFIRINOX方案作为晚期和复发性胆道癌患者一线治疗方案的疗效。
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-022-01322-7
Takahara, Naminatsu; Nakai, Yousuke; Isayama, Hiroyuki; Sasaki, Takashi; Morine, Yuji; Watanabe, Kazuo; Ueno, Makoto; Ioka, Tatsuya; Kanai, Masashi; Kondo, Shunsuke; Okano, Naohiro; Koike, Kazuhiko